A detailed history of Meyer Handelman CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Meyer Handelman CO holds 575 shares of VRTX stock, worth $258,962. This represents 0.01% of its overall portfolio holdings.

Number of Shares
575
Previous 575 -0.0%
Holding current value
$258,962
Previous $269,000 0.74%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024

BUY
$343.0 - $410.68 $197,225 - $236,141
575 New
575 $233,000
Q2 2023

Jul 21, 2023

BUY
$314.42 - $351.91 $180,791 - $202,348
575 New
575 $202,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Meyer Handelman CO Portfolio

Follow Meyer Handelman CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.